Table 2 Clinical indications for CRS and HIPEC
Clinical indication | Number | Percentage |
|---|---|---|
Carcinoma of the ovary | 131 | 56.5% |
Pseudomyxoma peritonei | 43 | 18.5% |
Colorectal cancer | 31 | 13.4% |
Malignant mesothelioma | 13 | 5.6% |
Gastric carcinoma | 6 | 2.6% |
Endometrial stromal sarcoma | 5 | 2.2% |
Granulosa cell tumor | 3 | 1.3% |